Clinical Study on Efficacy and Safety of Wet Cupping in Managing Vasomotor Rhinitis

INTERVENTION: Intervention1: Hijama Bil Shart Wet Cupping: The patient will be advised to lie in the prone position on the bed. Aseptic measures will be taken before performing the procedure. The dry cupping will be perform 3 no. (medium size) two cups will be place, cup 1 is applied slightly lateral (about 2‐3 cm) to the left of the level of C2‐C4 spinous process, cup 2 is applied slightly lateral (about 2‐3 cm) to the right of the level of C2‐C4 spinous process for 3‐5 minutes under negative pressure and then will be removed and the site will be scarified with surgical blade no. 11 and the cups will be reapplied for 6‐7 minutes under negative pressure and then removed followed by cleaning of area with antispetic and sterile dressing will be done weekly for 4 weeks. Control Intervention1: Levocetirizine 5mg: Enrolled cases in Standard Control Group will be treated by standard drug, Levocetirizine 5mg once a day HS for 28 days CONDITION: Health Condition 1: J300‐ Vasomotor rhinitis PRIMARY OUTCOME: Severity of VMR symptoms will be assessed on each sitting of the trial using a four‐point symptom rating scale of total vasomotor rhinitis symptom score. ; Change in total vasomotor rhinitis symptom score of vasomotor rhinitis from base line to end of treatment.Timepoint: On the day 0, 07, 14, 21 and 28 SECONDARY OUTCOME: The RQLQ Rhinoconjunctivitis Quality of Life Questionnaire score to assess QoL in of patients of vasomotor rhinitis.Timepoint: On the day 0, 07, 14, 21 and 28 INCLUSION CRITERIA: Patients diagnosed with VMR Patients of all sexes Patients ready for clinical trial